A platform for research: civil engineering, architecture and urbanism
A platform for research: civil engineering, architecture and urbanism
Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer
Clinical evidence indicates that drug resistance is a great obstacle in breast cancer therapy. It renders the disease uncontrollable and causes high mortality. Multiple mechanisms contribute to the development of drug resistance, but the underlying cause is usually a shift in the genetic composition of tumor cells. It is increasingly feasible to engineer the genome with the clustered regularly interspaced short palindromic repeats (CRISPR)/associated (Cas)9 technology recently developed, which might be advantageous in overcoming drug resistance. This article discusses how the CRISPR/Cas9 system might revert resistance gene mutations and identify potential resistance targets in drug‐resistant breast cancer. In addition, the challenges that impede the clinical applicability of this technology and highlight the CRISPR/Cas9 systems are presented. The CRISPR/Cas9 system is poised to play an important role in preventing drug resistance in breast cancer therapy and will become an essential tool for personalized medicine.
Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer
Clinical evidence indicates that drug resistance is a great obstacle in breast cancer therapy. It renders the disease uncontrollable and causes high mortality. Multiple mechanisms contribute to the development of drug resistance, but the underlying cause is usually a shift in the genetic composition of tumor cells. It is increasingly feasible to engineer the genome with the clustered regularly interspaced short palindromic repeats (CRISPR)/associated (Cas)9 technology recently developed, which might be advantageous in overcoming drug resistance. This article discusses how the CRISPR/Cas9 system might revert resistance gene mutations and identify potential resistance targets in drug‐resistant breast cancer. In addition, the challenges that impede the clinical applicability of this technology and highlight the CRISPR/Cas9 systems are presented. The CRISPR/Cas9 system is poised to play an important role in preventing drug resistance in breast cancer therapy and will become an essential tool for personalized medicine.
Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer
Chen, Yinnan (author) / Zhang, Yanmin (author)
Advanced Science ; 5
2018-06-01
13 pages
Article (Journal)
Electronic Resource
English
Bioorthogonal CRISPR/Cas9‐Drug Conjugate: A Combinatorial Nanomedicine Platform
| Wiley | 2023
Genome modification by CRISPR/Cas9
| British Library Online Contents | 2014
Efficient ssa‐mediated precise genome editing using crispr/cas9
| British Library Online Contents | 2018
Targeted CRISPR/Cas9 Lipid Nanoparticles Elicits Therapeutic Genome Editing in Head and Neck Cancer
| Wiley | 2025
Generation of eGFP and Cre knockin rats by CRISPR/Cas9
| British Library Online Contents | 2014